Uma Sinha, Chief Scientific Officer at Eidos Therapeutics, Inc. (EIDX), sold 5,000 shares at $27.16 ($136K) on 2019-05-23, disclosed to the SEC on 2019-05-28.
Open-market sale of $136k EIDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.16 | 4,200 | $114K | 83.6% |
| 2 | $27.88 | 800 | $22K | 16.4% |
| Total | $27.28 avg | 5,000 | $136K | 100% |
| Filing → |
| EIDX | SELL | 2020-10-30 | $456K | — | Filing → |
| EIDX | SELL | 2020-10-02 | $515K | — | Filing → |
| EIDX | SELL | 2019-12-20 | $1.5M | — | Filing → |